Jin‐Yuan Ho

First-in-Human Trial of EphA2-Redirected CAR T-Cells in Patients With Recurrent Glioblastoma: A Preliminary Report of Three Cases at the Starting Dose

Teer Ba, Jin‐Yuan Ho, Dandan Chen et al. · Frontiers in Oncology · 2021 · 99 citations · Full text

Medicine, Immunology, Oncology +17

Biosynthesis of Streptolidine Involved Two Unexpected Intermediates Produced by a Dihydroxylase and a Cyclase through Unusual Mechanisms

Chin‐Yuan Chang, Syue‐Yi Lyu, Yuchen Liu et al. · Angewandte Chemie International Edition · 2014 · 60 citations

Life Sciences, Biochemistry, Microbiology +9

Promoter usage regulating the surface density of CAR molecules may modulate the kinetics of CAR-T cells in vivo

Jin‐Yuan Ho, Lin Wang, Ying Liu et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 56 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

Evidence of long‐lasting anti‐CD19 activity of engrafted CD19 chimeric antigen receptor–modified T cells in a phase I study targeting pediatrics with acute lymphoblastic leukemia

Futian Ma, Jin‐Yuan Ho, Huan Du et al. · Hematological Oncology · 2019 · 54 citations · Full text

Medicine, Hematology, Oncology +17

Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors

Chung-Fan Hsieh, Jia-Rong Jheng, Guan-Hua Lin et al. · Emerging Microbes & Infections · 2020 · 50 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17